Onconetix Inc (ONCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ONCO | AZN | AMGN | GILD | VRTX |
| Company | Onconetix Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.4360 | 92.66 | 328.65 | 124.56 | 456.83 |
| High | 1.5000 | 92.88 | 329.77 | 125.00 | 458.36 |
| Low | 1.4050 | 92.36 | 325.83 | 122.95 | 453.50 |
| Latest | 1.4400 | 92.50 | 328.58 | 123.18 | 454.66 |
| Change | -0.0100 | -0.02 | -1.05 | -1.73 | -5.12 |
| % Change | -0.69% | -0.02% | -0.32% | -1.38% | -1.11% |
| Volume | 34,703 | 1,257,771 | 715,056 | 1,677,560 | 431,003 |
| 20-Day Average Volume | 52,259 | 5,061,909 | 2,989,657 | 6,772,046 | 1,331,681 |
| Previous Close | 1.4400 | 92.52 | 329.63 | 124.91 | 459.78 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.1248 | 91.14 | 327.89 | 122.61 | 452.73 |
| 20-Day Raw Stochastic | 3.24% | 86.13% | 49.55% | 59.15% | 76.52% |
| 20-Day Relative Strength | 31.67 | 60.05 | 53.54 | 52.12 | 56.86 |
| Weighted Alpha | -93.33 | +42.35 | +25.55 | +31.63 | +11.65 |
| Today's Opinion | 100% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.90% since 12/22/25 | +1.11% since 12/22/25 | -0.65% since 12/22/25 | -0.42% since 12/22/25 | -1.16% since 12/22/25 |
| Low | 1.3700 on 12/29/25 | 91.94 on 12/23/25 | 325.88 on 12/30/25 | 122.95 on 12/30/25 | 453.60 on 12/30/25 |
| High | 1.6599 on 12/24/25 | 93.10 on 12/23/25 | 334.38 on 12/24/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 1-Month | |||||
| %Chg | -48.56% since 11/28/25 | -0.16% since 11/28/25 | -4.70% since 11/28/25 | -1.75% since 11/28/25 | +4.92% since 11/28/25 |
| Low | 1.3700 on 12/29/25 | 89.28 on 12/12/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 423.45 on 12/01/25 |
| High | 3.2200 on 12/10/25 | 93.10 on 12/23/25 | 346.38 on 12/03/25 | 127.41 on 12/23/25 | 464.44 on 12/24/25 |
| 3-Month | |||||
| %Chg | -54.02% since 09/30/25 | +20.66% since 09/30/25 | +16.67% since 09/30/25 | +11.38% since 09/30/25 | +16.17% since 09/30/25 |
| Low | 1.3700 on 12/29/25 | 80.48 on 11/04/25 | 283.00 on 10/01/25 | 108.46 on 10/02/25 | 392.49 on 10/01/25 |
| High | 4.1900 on 10/09/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 464.44 on 12/24/25 |
| 6-Month | |||||
| %Chg | -70.02% since 06/30/25 | +32.47% since 06/30/25 | +17.91% since 06/30/25 | +11.51% since 06/30/25 | +2.19% since 06/30/25 |
| Low | 1.3700 on 12/29/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 5.3999 on 07/15/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,239 | 286,946,304 | 177,499,504 | 154,973,344 | 116,654,920 |
| Shares Outstanding, K | 1,555 | 3,101,452 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 2,520,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -58,690,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 300,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -8,780,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 3.42 | 0.31 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -6.25 on 11/13/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 06/01/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.33 | 15.22 | 15.23 | 30.24 |